BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28991928)

  • 1. Clinical significance of pretreatment serum levels of VEGF and its receptors, IL- 8, and their prognostic value in type I and II endometrial cancer patients.
    Kotowicz B; Fuksiewicz M; Jonska-Gmyrek J; Berezowska A; Radziszewski J; Bidzinski M; Kowalska M
    PLoS One; 2017; 12(10):e0184576. PubMed ID: 28991928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative serum levels of YKL 40 and CA125 as a prognostic indicators in patients with endometrial cancer.
    Kotowicz B; Fuksiewicz M; Jonska-Gmyrek J; Wagrodzki M; Kowalska M
    Eur J Obstet Gynecol Reprod Biol; 2017 Aug; 215():141-147. PubMed ID: 28624692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical usefulness of assessing VEGF and soluble receptors sVEGFR-1 and sVEGFR-2 in women with breast cancer.
    Thielemann A; Baszczuk A; Kopczyński Z; Kopczyński P; Grodecka-Gazdecka S
    Ann Agric Environ Med; 2013; 20(2):293-7. PubMed ID: 23772579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of VEGF and VEGF-C in patients with endometrial cancer.
    Dobrzycka B; Terlikowski SJ; Kowalczuk O; Kulikowski M; Niklinski J
    Eur Cytokine Netw; 2011 Mar; 22(1):45-51. PubMed ID: 21411409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment serum levels of bFGF and VEGF and its clinical significance in endometrial carcinoma.
    Dobrzycka B; Mackowiak-Matejczyk B; Kinalski M; Terlikowski SJ
    Gynecol Oncol; 2013 Mar; 128(3):454-60. PubMed ID: 23206584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
    Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M
    Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF and its receptors in dengue virus infection.
    Kalita J; Chauhan PS; Mani VE; Bhoi SK; Misra UK
    J Med Virol; 2015 Sep; 87(9):1449-55. PubMed ID: 25970161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating vascular endothelial growth factor (VEGF) and its soluble receptors in patients with chronic lymphocytic leukemia.
    Gora-Tybor J; Blonski JZ; Robak T
    Eur Cytokine Netw; 2005; 16(1):41-6. PubMed ID: 15809205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and Prognostic Performance of Serum Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factor Receptor 2, and Osteopontin for Gastrointestinal Cancers.
    Jiang L; Hochwald S; Deng S; Chen Y; Tan C; Zhong Q; Huang H
    Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative serum CA125: a useful marker for surgical management of endometrial cancer.
    Jiang T; Huang L; Zhang S
    BMC Cancer; 2015 May; 15():396. PubMed ID: 25964114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating serum levels of angiogenic factors and vascular endothelial growth factor receptors 1 and 2 in melanoma patients.
    Tas F; Duranyildiz D; Oguz H; Camlica H; Yasasever V; Topuz E
    Melanoma Res; 2006 Oct; 16(5):405-11. PubMed ID: 17013089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The assessment of the prognostic value of tumor markers and cytokines as SCCAg, CYFRA 21.1, IL-6, VEGF and sTNF receptors in patients with squamous cell cervical cancer, particularly with early stage of the disease.
    Kotowicz B; Fuksiewicz M; Jonska-Gmyrek J; Bidzinski M; Kowalska M
    Tumour Biol; 2016 Jan; 37(1):1271-8. PubMed ID: 26289850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia.
    Wierzbowska A; Robak T; Wrzesień-Kuś A; Krawczyńska A; Lech-Marańda E; Urbańska-Ryś H
    Eur Cytokine Netw; 2003; 14(3):149-53. PubMed ID: 14656688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profiling and significance of VEGF-A, VEGFR2, VEGFR3 and related proteins in endometrial carcinoma.
    Wang J; Taylor A; Showeil R; Trivedi P; Horimoto Y; Bagwan I; Ewington L; Lam EW; El-Bahrawy MA
    Cytokine; 2014 Aug; 68(2):94-100. PubMed ID: 24845798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum soluble tumour necrosis factor receptor type I concentrations independently predict prognosis in patients with breast cancer.
    Fuksiewicz M; Kowalska M; Kotowicz B; Rubach M; Chechlinska M; Pienkowski T; Kaminska J
    Clin Chem Lab Med; 2010 Oct; 48(10):1481-6. PubMed ID: 20578967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of VEGF-A/VEGFR1/VEGFR2 gene expression in patients with myelodysplastic syndrome].
    Kalitin NN; Dudina GA; Semochkin SV; Karamysheva AF
    Ter Arkh; 2017; 89(7):39-44. PubMed ID: 28766539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood concentrations of vascular endothelial growth factor and its soluble receptors (R1 and R2) in patients with adrenal cortex tumours treated by surgery.
    Jurczyńska J; Stepień T; Lawnicka H; Stepień H; Krupiński R; Kołomecki K; Kuzdak K; Komorowski J
    Endokrynol Pol; 2009; 60(1):9-13. PubMed ID: 19224499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 as prognostic biomarkers for uterine cervical cancer.
    Sawada M; Oishi T; Komatsu H; Sato S; Chikumi J; Nonaka M; Kudoh A; Osaku D; Harada T
    Int J Clin Oncol; 2019 Dec; 24(12):1612-1619. PubMed ID: 31236742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and predictive value of vascular endothelial growth factor and its soluble receptors, VEGFR-1 and VEGFR-2 levels in the sera of small cell lung cancer patients.
    Ustuner Z; Saip P; Yasasever V; Vural B; Yazar A; Bal C; Ozturk B; Ozbek U; Topuz E
    Med Oncol; 2008; 25(4):394-9. PubMed ID: 18317954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma.
    Al-Moundhri MS; Al-Shukaili A; Al-Nabhani M; Al-Bahrani B; Burney IA; Rizivi A; Ganguly SS
    World J Gastroenterol; 2008 Jun; 14(24):3879-83. PubMed ID: 18609713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.